SCHEMBL23947361

SCHEMBL23947361

c1ccc(-c2nc(-c3ccc4oc5c(-c6cccc7c6c6ccccc6n7-c6ccccc6)cccc5c4c3)nc(-c3cccc4oc5ccccc5c34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.35
MAPT P10636 4/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CB P42338 1/20 0.32
PRKDC P78527 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PTPRF P10586 2/20 0.31
PTPN2 P17706 2/20 0.31
PTPN1 P18031 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23947911 0.95 ALOX5 (0.38) ALOX5MAPTSIRT2SIRT1ALDH1A1
SCHEMBL21192241 0.95 ALOX5 (0.39) ALOX5MAPTSIRT2SIRT1ALDH1A1
SCHEMBL21192170 0.95 ALOX5 (0.36) ALOX5MAPTSIRT2SIRT1ALDH1A1
SCHEMBL22257803 0.95 ALOX5 (0.36) ALOX5MAPTSIRT2SIRT1ALDH1A1
SCHEMBL23947289 0.94 PRKDC (0.36) ALOX5MAPTALDH1A1HPGDTSHR
SCHEMBL23947913 0.93 ALOX5 (0.38) ALOX5MAPTALDH1A1HPGDTSHR
SCHEMBL23947900 0.93 KDM4E (0.35) MAPTSIRT2SIRT1ALDH1A1NPSR1
SCHEMBL21192259 0.93 MAPT (0.35) MAPTALDH1A1HPGDTSHRPIK3CD
SCHEMBL23947879 0.93 ALOX5 (0.37) ALOX5MAPTSIRT2SIRT1ALDH1A1
SCHEMBL23947908 0.93 ALOX5 (0.37) ALOX5MAPTSIRT2SIRT1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, UBE2L3, OPRL1 ALOX5 2287/4885MAPT 3639/4885SIRT2 924/4885
US-11873297-B2 Compound and organic light emitting device comprising the same CCNL2, UBE2L3, ARL1 ALOX5 2234/4885MAPT 3608/4885SIRT2 875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.